View this email in your browser

FDA Commissioner to Join DTC National for Exclusive Fireside Chat

We’re pleased to officially announce a major addition to the 2026 DTC National.

FDA Commissioner Marty Makary, MD, MPH, will join us for an exclusive fireside chat.

April 21, 2026 | 02:30 PM – 03:00 PM EST

This marks a rare opportunity to hear directly from the head of the FDA in a candid, moderated conversation focused on the evolving landscape of direct-to-consumer advertising.

Dr. Makary, a practicing surgeon and nationally recognized healthcare leader, was confirmed by the U.S. Senate in March 2025 as the 27th Commissioner of Food and Drugs.

About the Session

This fireside chat will be a moderated discussion between Dr. Makary and Bob Ehrlich, CEO of DTC Perspectives. The conversation will explore the FDA’s current thinking and broader direction as it relates to DTC advertising and industry engagement.

Attendees will gain insight into:

• The FDA’s current perspective on DTC advertising
• The broader regulatory environment and direction of oversight
• How the agency is approaching industry engagement today
• What these shifts could mean for marketers moving forward


This is a unique opportunity to hear directly from FDA leadership in an open, in-depth discussion.

We look forward to welcoming Dr. Makary to the DTC National stage.

MEET THE EXPERT

Marty Makary, MD, MPH

Commissioner of Food and Drugs

Food and Drug Administration



About Dr. Makary

Prior to joining the FDA, Dr. Makary was a surgical oncologist and professor at Johns Hopkins University, where he also founded the Center for Surgical Trials and Outcomes Research. A widely published physician and policy voice, he has authored more than 300 peer-reviewed articles and three New York Times bestselling books on healthcare, transparency, and cost.

He has led national research efforts across cancer care, public health, and patient safety, and is a member of the National Academy of Medicine.

Christopher Lee

Director – ELIQUIS Consumer Marketing

Pfizer

Randy Keim

Senior Director, HCP & Consumer Marketing

Sanofi

Kristine Saffrin

Associate Marketing Director, Patient Marketing

Alexion, AstraZeneca Rare Disease

Anna Tustison

Associate Director, Retail Marketing

Moderna

Michael D'Alelio

Director, US Consumer Marketing, NEMLUVIO

Galderma

Katie Van Horn MSW, MPH

Associate Director, Patient Marketing

Takeda Pharmaceuticals U.S.A., Inc.

Carolyn Austring

Executive Director, Marketing, Oncology

Bayer

Jeremy Truxal

VP of Marketing, Cologuard

Exact Sciences



Denise Campbell

VP Marketing Strategy, US Oncology and Enterprise Partnerships

Novartis

Jason Alongi

Senior Director Consumer Marketing

Tarsus Pharmaceuticals, Inc.

Sean Moriarty

Associate Director, Consumer Marketing

Lundbeck

Bonnie Jean Perkins

Senior Director, Lead for Global Patient Engagement Center of Excellence

Alexion Pharmaceuticals

The Regulatory Crossroads: What FDA Action Means for DTC

Creative That Breaks Through the Formula

AI in Action: From Concept to Approval

Beyond Television: The Expanding Media Mix

Culture, Celebrities, and Influence in Healthcare

Patient Storytelling That Drives Action

Reaching Diverse and Underserved Audiences

Real-World Case Studies from Leading Brands

Interactive Breakouts: Practical Solutions for Marketers

Networking and Awards Celebrations

Reserve Your Spot

Registration is open, and space is filling quickly!

• Secure access to all agenda sessions
• Join hundreds of senior DTC industry peers
• Attend multiple award ceremonies under one roof
• Lock in hotel rates before blocks sell out

Why the 2026 DTC National Matters More Than Ever

• Regulatory Uncertainty – Prepare for potential DTC bans & policy shifts
• Industry Evolution – Unlock the power of AI, omnichannel engagement, and patient-first marketing
• Unmatched Networking – Exclusive opportunities to connect with top pharma leaders
• Celebrate Excellence – Honor award-winning campaigns, creative innovators, and top marketers